Literature DB >> 11262418

Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.

E Piek1, W J Ju, J Heyer, D Escalante-Alcalde, C L Stewart, M Weinstein, C Deng, R Kucherlapati, E P Bottinger, A B Roberts.   

Abstract

A prominent pathway of transforming growth factor (TGF)-beta signaling involves receptor-dependent phosphorylation of Smad2 and Smad3, which then translocate to the nucleus to activate transcription of target genes. To investigate the relative importance of these two Smad proteins in TGF-beta1 signal transduction, we have utilized a loss of function approach, based on analysis of the effects of TGF-beta1 on fibroblasts derived from mouse embryos deficient in Smad2 (S2KO) or Smad3 (S3KO). TGF-beta1 caused 50% inhibition of cellular proliferation in wild-type fibroblasts as assessed by [(3)H]thymidine incorporation, whereas the growth of S2KO or S3KO cells was only weakly inhibited by TGF-beta1. Lack of Smad2 or Smad3 expression did not affect TGF-beta1-induced fibronectin synthesis but resulted in markedly suppressed induction of plasminogen activator inhibitor-1 by TGF-beta1. Moreover, TGF-beta1-mediated induction of matrix metalloproteinase-2 was selectively dependent on Smad2, whereas induction of c-fos, Smad7, and TGF-beta1 autoinduction relied on expression of Smad3. Investigation of transcriptional activation of TGF-beta-sensitive reporter genes in the different fibroblasts showed that activation of the (Smad binding element)(4)-Lux reporter by TGF-beta1 was dependent on expression of Smad3, but not Smad2, whereas activation of the activin response element-Lux reporter was strongly suppressed in S2KO fibroblasts but, on the contrary, enhanced in S3KO cells. Our findings indicate specific roles for Smad2 and Smad3 in TGF-beta1 signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11262418     DOI: 10.1074/jbc.M102382200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  136 in total

1.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.

Authors:  D Liu; B L Black; R Derynck
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

2.  Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair.

Authors:  Takashi Kanamoto; Ulf Hellman; Carl-Henrik Heldin; Serhiy Souchelnytskyi
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

3.  Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta.

Authors:  Shiyou Chen; Magdalena Kulik; Robert J Lechleider
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

4.  Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.

Authors:  Kathleen C Flanders; Christopher D Major; Alidad Arabshahi; Ekinadese E Aburime; Miya H Okada; Makiko Fujii; Timothy D Blalock; Gregory S Schultz; Anastasia Sowers; Mario A Anzano; James B Mitchell; Angelo Russo; Anita B Roberts
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-beta.

Authors:  Ester Piek; Maarten Van Dinther; W Tony Parks; John M Sallee; Erwin P Böttinger; Anita B Roberts; Peter Ten Dijke
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

6.  The TGFβ receptor-interacting protein km23-1/DYNLRB1 plays an adaptor role in TGFβ1 autoinduction via its association with Ras.

Authors:  Qunyan Jin; Wei Ding; Kathleen M Mulder
Journal:  J Biol Chem       Date:  2012-05-27       Impact factor: 5.157

7.  The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.

Authors:  Zuyue Sun; Jill Schriewer; Mingxin Tang; Jerry Marlin; Frederick Taylor; Ralph V Shohet; Eugene A Konorev
Journal:  J Mol Cell Cardiol       Date:  2015-12-11       Impact factor: 5.000

8.  Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis.

Authors:  Hiroyuki Higashiyama; Daisuke Yoshimoto; Yuji Okamoto; Hideo Kikkawa; Satoshi Asano; Mine Kinoshita
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

9.  Myostatin directly regulates skeletal muscle fibrosis.

Authors:  Zhao Bo Li; Helen D Kollias; Kathryn R Wagner
Journal:  J Biol Chem       Date:  2008-05-03       Impact factor: 5.157

10.  Hypoxia-activated Smad3-specific dephosphorylation by PP2A.

Authors:  Pekka T Heikkinen; Marika Nummela; Suvi-Katri Leivonen; Jukka Westermarck; Caroline S Hill; Veli-Matti Kähäri; Panu M Jaakkola
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.